ロード中...
Podocalyxin is a marker of poor prognosis in colorectal cancer
BACKGROUND: Over two decades ago, a proposal was that two different colorectal cancer (CRC) entities existed, based on tumour location either proximal (right) or distal (left) of the splenic flexure. Proximal and distal tumours exhibit different clinical, epidemiological, and biological characterist...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4226963/ https://ncbi.nlm.nih.gov/pubmed/25004863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-493 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|